316 related articles for article (PubMed ID: 16052393)
1. Changes in plasma coagulation markers with prophylactic treatment of low molecular weight heparin after cesarean section.
Hirota Y; Sakai M; Nakabayashi M
Semin Thromb Hemost; 2005 Jun; 31(3):253-60. PubMed ID: 16052393
[TBL] [Abstract][Full Text] [Related]
2. The rheological changes after cesarean section: The influence of low molecular weight or unfractionated heparin on the rheological properties of blood.
Heilmann L; Rath W; Pollow K; Bick RL
Clin Hemorheol Microcirc; 2007; 37(3):211-8. PubMed ID: 17726250
[TBL] [Abstract][Full Text] [Related]
3. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
[TBL] [Abstract][Full Text] [Related]
4. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
5. Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.
Blondon M; Perrier A; Nendaz M; Righini M; Boehlen F; Boulvain M; De Moerloose P
Thromb Haemost; 2010 Jan; 103(1):129-37. PubMed ID: 20062923
[TBL] [Abstract][Full Text] [Related]
6. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
Ellison J; Thomson AJ; Conkie JA; McCall F; Walker D; Greer A
Thromb Haemost; 2001 Dec; 86(6):1374-8. PubMed ID: 11776302
[TBL] [Abstract][Full Text] [Related]
7. Changes in Coagulation and Fibrinolysis in Post-Cesarean Section Parturients Treated With Low Molecular Weight Heparin.
Liu Z; Liu C; Zhong M; Yang F; Chen H; Kong W; Lv P; Chen W; Yao Y; Cao Q; Zhou H
Clin Appl Thromb Hemost; 2020; 26():1076029620978809. PubMed ID: 33296256
[TBL] [Abstract][Full Text] [Related]
8. No increase in hemorrhagic complications with thromboprophylaxis using low-molecular-weight heparin soon after cesarean section.
Watanabe T; Matsubara S; Usui R; Izumi A; Kuwata T; Suzuki M
J Obstet Gynaecol Res; 2011 Sep; 37(9):1208-11. PubMed ID: 21518131
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of thromboembolism with low molecular weight heparin (Fragmin) in obstetrics].
Krauss T; Rath W; Dittmer U; Kuhn W
Z Geburtshilfe Perinatol; 1994 Aug; 198(4):120-5. PubMed ID: 7975797
[TBL] [Abstract][Full Text] [Related]
10. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Bremme K; Lind H; Blombäck M
Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
[TBL] [Abstract][Full Text] [Related]
11. Laboratory evaluation of the effect of prophylaxis for thromboembolism with fractionated heparin in patients undergoing laparoscopic cholecystectomy.
Martínez Ramos C; López Pastor A; Núñez Peña JR; Ruiz de Gopegui M; Sanz López R; Jorgensen T; Pastor L; Tamames S
Rev Esp Enferm Dig; 2000 Jan; 92(1):27-35. PubMed ID: 10749595
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.
Weitz IC; Israel VK; Waisman JR; Presant CA; Rochanda L; Liebman HA
Thromb Haemost; 2002 Aug; 88(2):213-20. PubMed ID: 12195692
[TBL] [Abstract][Full Text] [Related]
13. Thrombophylaxis and bleeding complications after cesarean section.
Snijder CA; Cornette JM; Hop WC; Kruip MJ; Duvekot JJ
Acta Obstet Gynecol Scand; 2012 May; 91(5):560-5. PubMed ID: 22229365
[TBL] [Abstract][Full Text] [Related]
14. Thromboprophylaxis after cesarean section: decision analysis.
Blondon M
Thromb Res; 2011 Feb; 127 Suppl 3():S9-S12. PubMed ID: 21262452
[TBL] [Abstract][Full Text] [Related]
15. Changes in D-dimer levels after cesarean section in women with singleton and twin pregnancies.
Morikawa M; Yamada T; Yamada T; Akaishi R; Koyama T; Minakami H
Thromb Res; 2011 Oct; 128(4):e33-8. PubMed ID: 21645918
[TBL] [Abstract][Full Text] [Related]
16. Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy.
Alguel G; Vormittag R; Simanek R; Kyrle PA; Quehenberger P; Mannhalter C; Husslein P; Pabinger I
Thromb Haemost; 2006 Sep; 96(3):285-9. PubMed ID: 16953268
[TBL] [Abstract][Full Text] [Related]
17. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of low molecular weight heparin.
Fletcher JP; Ao PY; Hawthorne WJ
ANZ J Surg; 2004 Sep; 74(9):793-6. PubMed ID: 15379813
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in obstetrics and gynecology.
Krivak TC; Zorn KK
Obstet Gynecol; 2007 Mar; 109(3):761-77. PubMed ID: 17329532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
